164 related articles for article (PubMed ID: 31008112)
1. Relationship of Natriuretic Peptides with Left Atrial Structure and Function within 1 Month after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation.
Karaliute R; Jureviciute J; Jurgaityte J; Stanaitiene G; Mizariene V; Kazakevicius T; Urboniene D; Kavoliuniene A
Biomed Res Int; 2019; 2019():7636195. PubMed ID: 31008112
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved.
Karaliūtė R; Leleika A; Apanavičiūtė I; Kazakevičius T; Mizarienė V; Zabiela V; Kavoliūnienė A; Ragaišytė N; Urbonienė D; Šakalytė G
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013520
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
[TBL] [Abstract][Full Text] [Related]
4. Atrial asynchrony and function before and after electrical cardioversion for persistent atrial fibrillation.
Dell'Era G; Rondano E; Franchi E; Marino PN;
Eur J Echocardiogr; 2010 Aug; 11(7):577-83. PubMed ID: 20400765
[TBL] [Abstract][Full Text] [Related]
5. Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion.
Bartkowiak R; Wozakowska-Kapłon B; Janiszewska G
Kardiol Pol; 2010 Jan; 68(1):48-54. PubMed ID: 20131188
[TBL] [Abstract][Full Text] [Related]
6. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
7. Biatrial remodelling in atrial fibrillation: A three-dimensional and strain echocardiography insight.
Soulat-Dufour L; Lang S; Ederhy S; Ancedy Y; Beraud AS; Adavane-Scheuble S; Chauvet-Droit M; Hammoudi N; Scheuble A; Nhan P; Charbonnier M; Boccara F; Cohen A
Arch Cardiovasc Dis; 2019 Oct; 112(10):585-593. PubMed ID: 31540880
[TBL] [Abstract][Full Text] [Related]
8. The significance of the left atrial volume index in cardioversion success and its relationship with recurrence in patients with non-valvular atrial fibrillation subjected to electrical cardioversion: a study on diagnostic accuracy.
Akdemir B; Altekin RE; Küçük M; Yanikoğlu A; Karakaş MS; Aktaş A; Demir İ; Ermiş C
Anadolu Kardiyol Derg; 2013 Feb; 13(1):18-25. PubMed ID: 23070632
[TBL] [Abstract][Full Text] [Related]
9. Echocardiographic assessment of left atrial morphology and function to predict maintenance of sinus rhythm after electrical cardioversion in patients with non-valvular persistent atrial fibrillation and normal function or mild dysfunction of left ventricle.
Wałek P; Sielski J; Starzyk K; Gorczyca I; Roskal-Wałek J; Wożakowska-Kapłon B
Cardiol J; 2020; 27(3):246-253. PubMed ID: 31313277
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
11. Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?
Kosior DA; Szulc M; Opolski G; Torbicki A; Rabczenko D
Heart Vessels; 2006 Nov; 21(6):375-81. PubMed ID: 17143714
[TBL] [Abstract][Full Text] [Related]
12. Left atrial wall dyskinesia assessed during contractile phase as a predictor of atrial fibrillation recurrence after electrical cardioversion performed due to persistent atrial fibrillation.
Wałek P; Ciesla E; Gorczyca I; Wożakowska-Kapłon B
Medicine (Baltimore); 2020 Dec; 99(49):e23333. PubMed ID: 33285712
[TBL] [Abstract][Full Text] [Related]
13. Association between left atrial phasic conduit function and early atrial fibrillation recurrence in patients undergoing electrical cardioversion.
Degiovanni A; Boggio E; Prenna E; Sartori C; De Vecchi F; Marino PN;
Clin Res Cardiol; 2018 Apr; 107(4):329-337. PubMed ID: 29181725
[TBL] [Abstract][Full Text] [Related]
14. Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure.
von Roeder M; Blazek S; Rommel KP; Kresoja KP; Gioia G; Mentzel L; Lurz JA; Besler C; Fengler K; Hindricks G; Desch S; Thiele H; Lurz P
Clin Res Cardiol; 2022 Sep; 111(9):1028-1039. PubMed ID: 34932171
[TBL] [Abstract][Full Text] [Related]
15. Serial evaluation of left atrial dimension after cardioversion for atrial fibrillation and relation to atrial function.
Mattioli AV; Sansoni S; Lucchi GR; Mattioli G
Am J Cardiol; 2000 Apr; 85(7):832-6. PubMed ID: 10758922
[TBL] [Abstract][Full Text] [Related]
16. The mechanical fibrillation pattern of the atrial myocardium is associated with acute and long-term success of electrical cardioversion in patients with persistent atrial fibrillation.
De Vos CB; Limantoro I; Pisters R; Delhaas T; Schotten U; Cheriex EC; Tieleman RG; Crijns HJ
Heart Rhythm; 2014 Sep; 11(9):1514-21. PubMed ID: 24768608
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH
Am J Cardiol; 2017 Oct; 120(8):1309-1315. PubMed ID: 28865890
[TBL] [Abstract][Full Text] [Related]
18. Atrial apoptosis and fibrosis adversely affect atrial conduit, reservoir and contractile functions.
Gasparovic H; Cikes M; Kopjar T; Hlupic L; Velagic V; Milicic D; Bijnens B; Colak Z; Biočina B
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):223-30; discussion 230. PubMed ID: 24722519
[TBL] [Abstract][Full Text] [Related]
19. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion.
Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Arnesen H; Smith P
Int J Cardiol; 2009 Jan; 131(2):234-9. PubMed ID: 18201783
[TBL] [Abstract][Full Text] [Related]
20. Incomplete recovery of mechanical and endocrine left atrial functions one month after electrical cardioversion for persistent atrial fibrillation: a pilot study.
Bernard-Brunet A; Saint Etienne C; Piver E; Zannad N; Pagés JC; Fauchier L; Babuty D
J Transl Med; 2014 Feb; 12():51. PubMed ID: 24559296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
